Articles tagged with Microbial Infections
A Dartmouth-led study reveals that cystic fibrosis disrupts the maturation of the gut microbiome in infants, leading to a depletion of health-associated bacteria and potentially poor health outcomes. The study found that the microbiomes of infants with CF remained stunted or delayed in their development compared to healthy infants.
Researchers found that flagellin from the gut disrupts immune checkpoint treatment in ovarian cancer patients. Inhibiting this pathway may enhance clinical outcomes and save lives. The discovery could lead to novel therapies capable of targeting ovarian tumors.
A new retrospective study found that nearly half of patients with fever of unknown origin in sub-Saharan Africa had a detectable pathogen, including bacterial strains and hemorrhagic fever viruses. The study highlights the need for strengthened laboratory capacity to improve diagnosis and treatment.
Researchers at TUM have developed a new therapeutic approach combining dietary therapy with fecal microbiome transfer to sustain inflammation-free states in Crohn's disease patients. The study found that the gut microbiome changes as a result of dietary therapy contribute to treatment success.
A study found that two liver graft preservation methods differ in their effect on gut microbiota composition and function following liver transplantation. The NMP cohort showed enrichment of beneficial gut taxa, while the static cold storage cohort depleted such taxa. Notable differences were observed between the two preservation methods.
A new Weizmann Institute study identified all proteins in a stool sample – those from the microbiome, human body, and food – revealing secrets of the intestines and their impact on human disease. The method, dubbed IPHOMED, decodes microbiome activity by showing which proteins come from bacterial strains and amounts.
A comprehensive study reveals that Akkermansia muciniphila breaks down sugars locked in mucus using a set of enzymes. The findings provide new insights into the molecular mechanisms behind this process and its potential applications in understanding disease and improving gut health.
Researchers at John Innes Centre have discovered a biological mechanism that enhances partnerships between plant roots and soil microbes, increasing nutrient uptake. This finding holds great potential for advancing sustainable agriculture by reducing the need for inorganic fertilizers.
A study published in Pediatric Investigation found that microbial cell-free DNA testing predicted infectious organisms consistent with traditional culturing tests in 26.9% of pediatric patients, but its utility was variable due to factors like antibiotic exposure and contamination.
A new self-destructing vaccine provides improved safety and protection against TB in macaque monkeys, outperforming the standard BCG vaccine. The 'kill switch' mechanism eliminates the risk of accidental infection, offering a safer vaccination option for immunocompromised individuals.
Scientists at University of California - Riverside discovered a chemical produced by plants that prevents bacterial biofilm formation. This breakthrough offers potential advances in healthcare and industrial settings, where biofilms cause significant problems.
A study by Michigan Medicine researchers suggests that sulfur-producing bacteria may be behind lingering Crohn's disease symptoms, even in the absence of inflammation. The study found that these bacteria can lead to increased visceral hypersensitivity and altered intestinal permeability, contributing to persistent symptoms.
Engineered yeast cells can form cooperative groups that perform complex tasks and self-regulate in response to external signals. This approach enables precise production of therapeutic compounds, reducing waste and increasing treatment efficacy.
A six-year study examining 38 clinical isolates of Cryptococcus found genes and gene alleles associated with disease severity. The research aims to develop new treatments targeting these genetic variations, predicting disease outcomes and improving patient care.
Pusan National University researchers have identified genes that are overexpressed in peri-implantitis, a condition similar to periodontitis but with higher recurrence rates. The study's findings may help diagnose and treat the disease with targeted therapies.
Researchers identified a protein that inhibits human defense mechanisms and allows fungal growth. The study suggests that the lack of this enzyme makes the fungus more prone to elimination by the immune system.
A recent machine learning study suggests that the association between gut bacteria and disease may be overstated. Instead, changes in microbial load were found to be a key factor in the presence of disease-associated microbial species. This discovery challenges current understanding of the gut microbiome's role in disease etiology.
Researchers at Houston Methodist have identified a new strain of bacteria, Streptococcus dysgalactiae subspecies equisimilis (SDSE), linked to increasingly severe human infections. The study used integrative analysis to investigate the genome, transcriptome, and virulence of SDSE strains, shedding light on their molecular pathogenesis.
A new study found compositional and functional differences in the gut microbiota of Chinese long-living adults (over 90 years) compared to elderly adults (65–74 years). The researchers noted lower relative abundances of bacteria in certain genera, which may regulate biological processes like autophagy and telomere maintenance. These fi...
A new study has found that rifaximin, an antibiotic commonly prescribed for liver disease patients, is driving the emergence of a deadly superbug. The antibiotic triggers specific changes in bacteria that make them resistant to last-resort antibiotics like daptomycin.
Researchers found that the presence of a fungus increases the pH of the soil, promoting growth of beneficial bacteria. This interaction could lead to sustainable agricultural practices by harnessing microbial interactions to combat plant diseases.
A new study reveals how three species of bacteria coexist in biofilms by playing a game of 'nice' and then moving out when the surface becomes too crowded. The dominant species, Pseudomonas aeruginosa, disperses to allow other species to thrive.
Researchers will showcase results of a randomized clinical trial demonstrating Biovanta's efficacy in reducing common cold symptoms by strengthening the respiratory barrier and controlling inflammation. The presentation will also include preclinical data on antiviral formulas targeting rhinovirus and influenza.
Researchers have discovered that Listeria monocytogenes loses its cell wall and becomes round when entering a dormant state, making it undetectable by growth-based tests. Developing antibodies to detect dormant forms of the bacterium could lead to specific tests for better protection.
A new study published in PNAS suggests that delivering microparticles containing CCL2 directly to the gums can inhibit bone loss and speed up bone repair in a mouse model of periodontal disease. The therapy modulates the immune response, shifting macrophages from inflammatory M1 type to anti-inflammatory M2 type.
Researchers have conducted the largest genomic survey of the syphilis bacterium to date, correlating genetic data with clinical information to identify potential targets for a vaccine. The study found differences in bacterial strains between continents, but also similarities that suggest a global vaccine could be effective.
Researchers at WVU are working on a project to inhibit the myeloperoxidase enzyme, which feeds pancreatic cancer growth. By targeting this enzyme, they hope to boost the body's immune system to fight cancer, showing promise in mouse models and potential for future clinical trials.
A study led by Cesar de la Fuente and his team has uncovered sequences for infection-fighting molecules in the genomic data of extinct species. These ancient β-defensins may lead to the creation of new antimicrobial therapies, including antibacterial, antifungal, and antiviral treatments.
A study by researchers from Brazil and Germany found that a surface protein on Aspergillus fumigatus spores suppresses the release of pro-inflammatory substances by immune cells, making it easier for the fungus to infect the body. The enzyme glycosylasparaginase plays a crucial role in this process.
A subset of CD4 T cells create an anti-inflammatory environment within the lung tissue, protecting against TB reinfection by limiting bacterial growth and disease severity. The discovery complements previous research on protective immune T cells in controlling TB infection, suggesting a potential key to improving existing vaccines.
Researchers identify accessory genes linked to nitric oxide production that contribute to Foc TR4's virulence, offering potential treatments and strategies to slow its spread. Monocropping is also identified as a key factor in the disease's success, highlighting the importance of crop diversity.
A new index uses inflammatory cell proportions to predict tissue healing and outcomes in patients with ulcerative colitis. The index, called the inflammatory cell enumeration index (ICEI), was developed by analyzing data from 220 patients who achieved healing.
Researchers found that certain flu viruses can use a second entry pathway, MHC class II protein complexes, to infect human and animal cells. This ability helps the viruses infect different species and potentially jump between animals and humans.
Researchers identify key steps in Pseudogymnoascus destructans infection, including epidermal growth factor receptor co-optation and manipulation of keratinocytes. The discovery opens potential treatment possibilities using FDA-approved drug gefitinib.
The team created stable microbial therapeutics using synthetic extremophiles, maintaining potency and function over time despite extreme temperatures and harsh manufacturing processes. These formulations have potential applications in healthcare, agriculture, and space exploration.
Researchers have identified 31 effector genes from the fungus Ceratocystis fimbriata, which causes devastating black rot in sweetpotatoes. This breakthrough provides a new approach to developing disease-resistant crops using effector-assisted breeding.
Researchers uncover how grafting onto resistant rootstocks changes root exudates, reducing pathogenic Agrobacterium and enhancing plant defense mechanisms. The study suggests grafting can minimize chemical pesticide use, boosting eco-friendly farming and crop health.
A team of researchers created a microfluidic human cervix model that replicates the complex interactions between cervical epithelial cells, mucus production, and microbiome. The Cervix Chip technology offers a new testbed for bacterial vaginosis therapeutics and other treatments, addressing a key women's health gap.
A study from the University of Notre Dame identifies fibrinolytic deficiencies as a key factor increasing risk for catheter-associated urinary tract infections (CAUTIs) and sepsis in catheterized patients. The research suggests that antifibrinolytic medications may be linked to this increased risk.
A new study highlights the benefits of intermittent fasting and protein-pacing on gut health, weight loss, and metabolic responses. Participants showed improved diversity of the gut microbiota, decreased symptoms of gastrointestinal problems, and increased beneficial microbes linked to a lean body type.
Researchers created a new model to study the effects of undernutrition on the microbiome, which can help identify specific microbes that impact development. The model mimics early childhood experiences and shows promise in understanding the underlying causes of stunted growth and other harmful effects of undernutrition.
Astragalus polysaccharide regulates VRC metabolism by increasing Bifidobacterium bifidum abundance and reducing inflammation in the liver. This leads to improved VRC metabolism, with high-dose APS showing stronger effects.
Researchers found that gut bacteria-generated linoleic acid metabolite KetoC markedly reduced inflammation and immune cell expansion. gKetoC also suppressed prolonged T-cell proliferation and dendritic cell activation. The study suggests a potential molecular axis governing the immunomodulatory effects of gKetoC.
Researchers at U of T have identified two compounds, diindolylmethane and diindolylethane, produced by gut bacteria that can regulate the nuclear receptor CAR, potentially treating diseases like diabetes, fatty liver disease, and small intestine ulcerative colitis.
Researchers at George Mason University have developed a urine test for Lyme disease that detects the bacteria causing the infection, leading to earlier treatment and prevention of long-term debilitating effects. The test has shown high sensitivity and specificity, and will be made available through telehealth to increase accessibility.
Researchers found that altering a male mouse's gut microbiota increases the probability of low birth weight and premature death in their offspring. The study suggests a 'gut-germline axis' exists, connecting the gut microbiota to the germline and potentially influencing inherited traits.
Decreased gut bacterial diversity was found in patients with NAFLD, while Faecalibacterium and Ruminococcus 2 were associated with the disease. The study identified a combination of microbiomes and biochemical indexes that distinguished NAFLD from normal livers.
Grafting onto a disease-resistant rootstock reduces pathogenic Agrobacterium abundance and alters the microbiome composition, enriching beneficial bacteria. The decreased valine in root exudates from grafted plants contributes to decreasing Agrobacterium abundance and suppressing crown gall disease.
A new study reveals that gut microbiota significantly impacts host amino acid and glucose metabolism, leading to a second liver-like function. The research identifies specific bacterial metabolic genes responsible for depleting amino acids, which can be targeted to treat conditions such as type 2 diabetes and inflammatory bowel disease.
Researchers used machine learning to analyze over 1.09 million potential metabolite-receptor pairs and predict the likelihood that each interaction contributed to Alzheimer's disease. The study found a protective metabolite called agmatine interacting with a receptor called CA3R in brain cells, reducing CA3R levels and lowering phospho...
Researchers at Uppsala University have developed a new class of antibiotics targeting LpxH protein in Gram-negative bacteria, showing potent activity against multidrug-resistant strains. The discovery holds promise for treating bloodstream infections and has potential for future clinical trials.
Researchers have identified distinct molecular signatures associated with sepsis, enabling more accurate diagnosis and prognosis. The study's findings suggest a potential new tool to target specific therapies at patients most likely to develop severe symptoms.
Researchers have recovered ancient microbiomes from 4,000-year-old teeth in Ireland, revealing major changes in oral microenvironments. The study identified bacteria linked to gum disease and provided the first high-quality ancient genome of Streptococcus mutans, a major culprit behind tooth decay.
Researchers analyzed well-preserved microbiomes from 4,000-year-old teeth in Ireland, providing a snapshot of oral health in the past. The study found evidence of dysbiosis and an unusual abundance of S. mutans bacteria, suggesting that our ancestors' mouths differed significantly from ours.
Research reveals a significant connection between oral bacteria and accelerated pancreatic cancer development in mice. Viable Porphyromonas gingivalis was found in the pancreas of healthy mice after gum application, causing changes in the organ's microbial balance.
Researchers at Leibniz-HKI deciphered the function of Candidalysin's unusual protein structure, which reduces pathogenicity and opens up new treatment options. Nanobodies neutralize the toxin, blocking its activity and inhibiting tissue damage.
A new study finds that Latinx children with unreliable access to food at age 4 are nearly four times more likely to develop fatty liver disease later. The researchers recommend earlier screening for metabolic dysfunction-associated steatotic liver disease (MASLD) and ensuring public meal programs offer nutritious meals.
Researchers decode underlying mechanisms of DCM, hippocampal neurotoxicity, and dysbiosis mediated AD progression using mass spectrometry imaging. The studies found metabolic changes in DCM rat hearts and regulation of CYPs in the hippocampus, providing new perspectives on treatment strategies.
The American Gastroenterological Association recommends fecal microbiota transplant (FMT) as a safe and effective treatment for most patients with recurrent Clostridioides difficile infection. FMT offers hope to patients suffering from debilitating C. diff, enabling them to lead happy and healthy lives.
Frequent consumption of ultra-processed foods in the US diet is associated with increased rates of colorectal cancer and other gastrointestinal diseases. This may be attributed to additives such as emulsifiers that can disrupt the balance of gut microbiota, leading to disease promotion.